Evidence map›Paper›PMID 41419633›Full record

ArticleNPJ digital medicine2025

An AI-powered tongue image model for home-based monitoring of liver fibrosis.

Xiao-Zhou Lu, Shuai Liu, Xin-Xin Lin, Yue Zeng, Ji-Hang Chen, Wei-Ping Ke, Jin-Feng Deng, Mei-Qing Cheng, Wei Li, Li-Da Chen and 4 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiao-Zhou Lu *Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Shuai Liu *School of Physics and Electronic Information, Guangxi Minzu University, Nanning, China.
Xin-Xin Lin *Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, MedAI Collaborative Lab, Ultrasomics Artificial Intelligence X-Lab, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Yue Zeng *Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, MedAI Collaborative Lab, Ultrasomics Artificial Intelligence X-Lab, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Ji-Hang Chen *Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, MedAI Collaborative Lab, Ultrasomics Artificial Intelligence X-Lab, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Wei-Ping KeDepartment of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, MedAI Collaborative Lab, Ultrasomics Artificial Intelligence X-Lab, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Jin-Feng DengDepartment of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Mei-Qing ChengDepartment of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, MedAI Collaborative Lab, Ultrasomics Artificial Intelligence X-Lab, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Wei LiDepartment of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, MedAI Collaborative Lab, Ultrasomics Artificial Intelligence X-Lab, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Li-Da ChenDepartment of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, MedAI Collaborative Lab, Ultrasomics Artificial Intelligence X-Lab, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Zhen-Kun LuSchool of Physics and Electronic Information, Guangxi Minzu University, Nanning, China. lzk06@sina.com.
Bao-Guo SunDepartment of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. sunbaog@mail.sysu.edu.cn.
Hang-Tong HuDepartment of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, MedAI Collaborative Lab, Ultrasomics Artificial Intelligence X-Lab, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. huht5@mail.sysu.edu.cn.
Wei WangDepartment of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, MedAI Collaborative Lab, Ultrasomics Artificial Intelligence X-Lab, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. wangw73@mail.sysu.edu.cn.

Funding

Guangxi Key Research and Development Program GuikeAB25069464Guangxi Science and Technology Major Special Project GuikeAA23073013National Natural Science Foundation of China 82272076National Natural Science Foundation of China 82371983
6 · The paper itself

Abstract

Liver fibrosis is a reversible precursor to cirrhosis, and early detection is key to halting disease progression. Tongue diagnosis provides a non-invasive and cost-effective insight into internal health; however, its subjectivity limits clinical reliability. We developed TongVMoe, a multi-task deep learning model trained on 2202 tongue images from 1601 patients, to detect liver fibrosis and simultaneously classify seven key tongue features. The model achieved an area under the curve (AUC) of 0.8061, outperforming State-of-the-Art methods such as DiffMIC-v2 (0.6929), HorNet (0.7018), InceptionNeXt (0.7012), LSNet (0.6971), and TransXNet (0.7062). TongVMoe also demonstrated robust recognition of tongue features, with AUCs of 0.9752 for cracks and 0.9232 for greasy coating. Among these features, petechiae emerged as a significant clinical indicator, showing a strong correlation with liver fibrosis (χ² = 19.516, P < 0.001). We further integrated the model into a WeChat mini-program and simulated remote screening, achieving an accuracy of 77.8% and a sensitivity of 86.2%. These findings suggest that the TongVMoe has the potential to serve as an interpretable and mobile-compatible tool for the early detection and monitoring of liver fibrosis, particularly in resource-limited areas. Trial registration: Chinese Clinical Trial Registry (ChiCTR2100053676, registered 27 November 2021).

Identifiers

PMID41419633
PMCPMC12827268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.